Group 1: Product Development and Technology - Beijing Dingcheng Peptide Source Biotechnology Co., Ltd. has developed a complete technical platform for TCR-T and CAR-T cell therapy products targeting pancreatic cancer, colorectal cancer, gastric cancer, liver cancer, and glioma, with over 10 cell therapy products in development [2][3] - The cost reduction potential for Dingcheng Peptide Source's cell therapy products will depend on technological innovation, R&D investment, market competition, and policy support, with strong R&D capabilities aiding in optimizing production processes [3][4] Group 2: Cost Management and Efficiency - The newly launched steam cost information accounting system integrates industrial internet technology and big data analysis, enabling automatic and precise accounting of steam costs, which supports production decision-making [5] - The system can calculate various energy consumption metrics, providing detailed data to enhance energy utilization and reduce production costs [5] Group 3: Marketing and Sales Strategy - Northeast Pharmaceutical focuses on terminal development, enhancing pure sales, academic promotion, refined management, and market share expansion to improve work efficiency [6][7] - The company actively adjusts its sales structure and develops new products to increase market share and sales potential, while implementing personalized incentive policies to enhance the sales capabilities of agents [6][7] Group 4: Talent Acquisition and Innovation - The large-scale recruitment of postgraduate talents aims to strengthen R&D capabilities, ensuring the effective implementation of the company's transformation strategy and enhancing its leading position in the generic drug sector [7] - This recruitment reflects the company's commitment to technological innovation and confidence in future development, aiming to create a supportive environment for employee growth and motivation [7]